DUBLIN, Ireland, April 07, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected to the Crain’s Chicago Business 2017 “Best Places To Work” list.
“Horizon is a fast-growing company that takes great pride in building and maintaining a diverse and collaborative culture,” said Timothy P. Walbert, chairman, president and chief executive officer. “We know that our employee base is our greatest asset. This honor reinforces our commitment to making Horizon a great place to work which we do, in part, by attracting the best and brightest talent in the industry.”
The Crain's Chicago Business 2017 “Best Places To Work" designation is based on surveys conducted by Conduent, a global human resources organization. The firm surveyed Chicago-area businesses and employees about company benefits, pay, hiring practices, relationships with management and career development. This year, more than 14,900 Chicago-area employees participated. The complete report can be found at www.chicagobusiness.com.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Geoff Curtis Senior Vice President, Corporate Communications [email protected]


U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 



